The Hospice Advanced Dementia Symptom Management and Quality of Life Trial (HAS-QOL)
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Dementia
- Sponsor
- NYU Langone Health
- Enrollment
- 83
- Locations
- 1
- Primary Endpoint
- Percentage of Hospice IDT Members Who Complete Required Education and Training
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Alzheimer's Disease and Related Disorders (dementia) are a group of serious life limiting illness that cause significant challenges to our public health system, with significant illness burden for both the person with dementia and the caregiver. At the end of life, over 230,000 persons with dementia annually are cared for in hospice, yet hospice agencies are ill prepared to care for this population and often resort to inappropriate pharmacologic measures such as antipsychotics that reduce quality of life rather than improve it. This study will therefore through its two phases refine and then implement, using a pragmatic stepped wedge trial design, the Dementia Symptom Management at Home Program Hospice Edition, with the goal improving quality of care for the person with dementia and their caregiver, reducing antipsychotic use, and increasing bereaved caregiver satisfaction in the hospice setting.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Must have dementia as primary diagnosis for admission to hospice
- •Must be newly admitted to a participating hospice
- •Must be 50 years or older
- •Clinicians:
- •Must be a skilled clinician or home health aide who provides care through an eligible home health agency
- •Must be 18 years or older
Exclusion Criteria
- •Persons with Dementia:
- •Clinicians:
Outcomes
Primary Outcomes
Percentage of Hospice IDT Members Who Complete Required Education and Training
Time Frame: 2 Months
Percentage of Hospice IDT Members who Complete Required Education and Training